Giving the Thrombosis and Hemostasis Community a Voice to Drive Prioritisation

The European Thrombosis and Haemostasis Alliance (ETHA) has 28 member organizations within the European Union. If you would like to join this important cause of increasing the share of voice and driving prioritisation of thrombosis ...
Header image

Statement from the International Society on Thrombosis and H...

Earlier this week, the European Medicines Agency (EMA) and UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) completed their assessments of extremely rare blood clotting events associated with low platelet counts tha...

Read more

European Thrombosis and Haemostasis Alliance Welcomes Europe...

18 March 2021 – The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the European Medicines Agency’s (EMA) decision today following the recent reports of thrombotic events (blood clots) following COVID-19 vaccina...

Read more

Saving and Improving Lives by Addressing Cancer-Associated T...

Cancer-associated thrombosis (blood clots) is a leading cause of death in cancer patients. It affects patients of all cancer types, at all cancer stages. It is essential that the Europe’s Beating Cancer Plan and the EU Cancer Miss...

Read more

European Thrombosis and Haemostasis Alliance Elects Prof. I...

The European Thrombosis and Haemostasis Alliance (ETHA) has elected Prof. Ingrid Pabinger-Fasching as the new chair of the Alliance for a term of two years. Pabinger-Fasching is Professor of Haemostaseology and Vice-Head of the Clin...

Read more

Watch the Recorded Webinar on the Role of Public Affairs

Watch the recorded ETHA / ISTH Webinar on Saving Lives by Addressing VTE Risk Assessments: The Role of Public Affairs

Read more

Joint Statement on Cancer-Associated Thrombosis with the Eur...

On World Thrombosis Day 2020, the European Thrombosis and Haemostasis Alliance (ETHA) and European Cancer Patient Coalition (ECPC) jointly call upon the European Commission to recognise the importance of cancer-associated thrombosis...

Read more

News

Statement from the International Society on Thrombosis and H...

Earlier this week, the European Medicines Agency (EMA) and UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) completed their assessments of extremely rare blood clotting events associated with low platelet counts tha...

Read more

European Thrombosis and Haemostasis Alliance Welcomes Europe...

18 March 2021 – The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the European Medicines Agency’s (EMA) decision today following the recent reports of thrombotic events (blood clots) following COVID-19 vaccina...

Read more

Saving and Improving Lives by Addressing Cancer-Associated T...

Cancer-associated thrombosis (blood clots) is a leading cause of death in cancer patients. It affects patients of all cancer types, at all cancer stages. It is essential that the Europe’s Beating Cancer Plan and the EU Cancer Miss...

Read more